Overall, our study explored the different effects of IDO and Treg cells on ovarian cancer cells under hypoxic conditions, and suggests that targeting IDO and Treg cels may constitute a suitable therapeutic route for ovarian cancer. This evidence concerns the gene IDO1 and ovarian carcinoma.